Fed Chair Powell claims lesser banks most likely will be exempt from better funds prerequisites

Vital Points

Federal Reserve Chairman Jerome Powell mentioned Thursday that banking companies underneath $100 billion in belongings will not be impacted by any new funds specifications.
The concerns, and the go to re-take a look at rules, adhere to the March tumult in the industry.
In independent testimony, FDIC Chair Martin Gruenberg mentioned the approaching principles could use so-called Basel III international specifications to banking institutions in the $100 billion to $250 billion asset assortment.

Source

Finance

Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet

November 14, 2025

Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. CNBC Warren Buffett’s Berkshire Hathaway revealed a new position in Alphabet, making the Google parent the conglomerate’s 10th largest equity holding at the end of September, according to a regulatory filing. Berkshire disclosed a $4.3 billion stake in […]

Finance

Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more

November 14, 2025

Check out the companies making the biggest moves midday: Scholar Rock — The Cambridge, Massachusetts-based biotech jumped 23% after saying it ” completed constructive and collaborative in-person Type A meeting ” with the FDA on Wednesday for a biologics license application for apitegromab, a spinal muscular atrophy treatment. Officials from Novo Nordisk’s Catalent Indiana joined […]

Finance

Stocks making the biggest premarket moves: Warner Bros. Discovery, Cidara Therapeutics, Avadel Pharmaceuticals and more

November 14, 2025

Check out the companies making headlines before the bell. Cidara Therapeutics — Shares of Cidara surged 103% after Merck agreed to buy the company for close to $9.2 billion in cash. Merck fell 1%. Avadel Pharmaceuticals — Danish drugmaker Lundbeck offered to acquire the pharmaceutical company for as much as $23 per share, topping biotech […]